The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Autoimmune Disease Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
The global Autoimmune Disease Therapeutics market size is expected to reach US$ 119350 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Autoimmune Disease Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinics, Independent Pharmacies and Others, are propelling Autoimmune Disease Therapeutics market. Immunosuppressants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-Inflammatory Drugs segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Autoimmune Disease Therapeutics market, driven by demand from China, the second largest economy with some signs of stabilising, the Autoimmune Disease Therapeutics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Autoimmune Disease Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Autoimmune Disease Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Autoimmune Disease Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Autoimmune Disease Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Autoimmune Disease Therapeutics covered in this report include Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen and Bayer, etc.
The global Autoimmune Disease Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis
Johnson & Johnson Services
Merck
Sanofi
Abott
Bristol-Myers Squibb
Amgen
Bayer
F. Hoffmann-La Roche
Eli Lilly and Company
Global Autoimmune Disease Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Autoimmune Disease Therapeutics market, Segment by Type:
Immunosuppressants
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Others
Global Autoimmune Disease Therapeutics market, by Application
Hospitals
Clinics
Independent Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Autoimmune Disease Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Autoimmune Disease Therapeutics market size is expected to reach US$ 119350 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Autoimmune Disease Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinics, Independent Pharmacies and Others, are propelling Autoimmune Disease Therapeutics market. Immunosuppressants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-Inflammatory Drugs segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Autoimmune Disease Therapeutics market, driven by demand from China, the second largest economy with some signs of stabilising, the Autoimmune Disease Therapeutics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Autoimmune Disease Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Autoimmune Disease Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Autoimmune Disease Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Autoimmune Disease Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Autoimmune Disease Therapeutics covered in this report include Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen and Bayer, etc.
The global Autoimmune Disease Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis
Johnson & Johnson Services
Merck
Sanofi
Abott
Bristol-Myers Squibb
Amgen
Bayer
F. Hoffmann-La Roche
Eli Lilly and Company
Global Autoimmune Disease Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Autoimmune Disease Therapeutics market, Segment by Type:
Immunosuppressants
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Others
Global Autoimmune Disease Therapeutics market, by Application
Hospitals
Clinics
Independent Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Autoimmune Disease Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Autoimmune Disease Therapeutics
1.1 Autoimmune Disease Therapeutics Market Overview
1.1.1 Autoimmune Disease Therapeutics Product Scope
1.1.2 Autoimmune Disease Therapeutics Market Status and Outlook
1.2 Global Autoimmune Disease Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Autoimmune Disease Therapeutics Market Size by Region (2018-2029)
1.4 Global Autoimmune Disease Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Autoimmune Disease Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Autoimmune Disease Therapeutics Market Size (2018-2029)
1.6.1 North America Autoimmune Disease Therapeutics Market Size (2018-2029)
1.6.2 Europe Autoimmune Disease Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size (2018-2029)
1.6.4 Latin America Autoimmune Disease Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Autoimmune Disease Therapeutics Market Size (2018-2029)
2 Autoimmune Disease Therapeutics Market by Type
2.1 Introduction
2.1.1 Immunosuppressants
2.1.2 Anti-Inflammatory Drugs
2.1.3 Corticosteroids
2.1.4 Nonsteroidal Anti-inflammatory Drugs
2.1.5 Biologics
2.1.6 Others
2.2 Global Autoimmune Disease Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Autoimmune Disease Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Autoimmune Disease Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Autoimmune Disease Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Autoimmune Disease Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Autoimmune Disease Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Autoimmune Disease Therapeutics Revenue Breakdown by Type (2018-2029)
3 Autoimmune Disease Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Independent Pharmacies
3.1.4 Others
3.2 Global Autoimmune Disease Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Autoimmune Disease Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Autoimmune Disease Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Autoimmune Disease Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Autoimmune Disease Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Autoimmune Disease Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Autoimmune Disease Therapeutics Revenue Breakdown by Application (2018-2029)
4 Autoimmune Disease Therapeutics Competition Analysis by Players
4.1 Global Autoimmune Disease Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Disease Therapeutics as of 2022)
4.3 Date of Key Players Enter into Autoimmune Disease Therapeutics Market
4.4 Global Top Players Autoimmune Disease Therapeutics Headquarters and Area Served
4.5 Key Players Autoimmune Disease Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Autoimmune Disease Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Autoimmune Disease Therapeutics Products, Services and Solutions
5.1.4 Pfizer Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Autoimmune Disease Therapeutics Products, Services and Solutions
5.2.4 Novartis Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Johnson & Johnson Services
5.3.1 Johnson & Johnson Services Profile
5.3.2 Johnson & Johnson Services Main Business
5.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Products, Services and Solutions
5.3.4 Johnson & Johnson Services Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Autoimmune Disease Therapeutics Products, Services and Solutions
5.4.4 Merck Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Autoimmune Disease Therapeutics Products, Services and Solutions
5.5.4 Sanofi Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Abott
5.6.1 Abott Profile
5.6.2 Abott Main Business
5.6.3 Abott Autoimmune Disease Therapeutics Products, Services and Solutions
5.6.4 Abott Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Abott Recent Developments
5.7 Bristol-Myers Squibb
5.7.1 Bristol-Myers Squibb Profile
5.7.2 Bristol-Myers Squibb Main Business
5.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Products, Services and Solutions
5.7.4 Bristol-Myers Squibb Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Bristol-Myers Squibb Recent Developments
5.8 Amgen
5.8.1 Amgen Profile
5.8.2 Amgen Main Business
5.8.3 Amgen Autoimmune Disease Therapeutics Products, Services and Solutions
5.8.4 Amgen Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Amgen Recent Developments
5.9 Bayer
5.9.1 Bayer Profile
5.9.2 Bayer Main Business
5.9.3 Bayer Autoimmune Disease Therapeutics Products, Services and Solutions
5.9.4 Bayer Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Bayer Recent Developments
5.10 F. Hoffmann-La Roche
5.10.1 F. Hoffmann-La Roche Profile
5.10.2 F. Hoffmann-La Roche Main Business
5.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Products, Services and Solutions
5.10.4 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 F. Hoffmann-La Roche Recent Developments
5.11 Eli Lilly and Company
5.11.1 Eli Lilly and Company Profile
5.11.2 Eli Lilly and Company Main Business
5.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Products, Services and Solutions
5.11.4 Eli Lilly and Company Autoimmune Disease Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Eli Lilly and Company Recent Developments
6 North America
6.1 North America Autoimmune Disease Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Autoimmune Disease Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Autoimmune Disease Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Autoimmune Disease Therapeutics Market Dynamics
11.1 Autoimmune Disease Therapeutics Industry Trends
11.2 Autoimmune Disease Therapeutics Market Drivers
11.3 Autoimmune Disease Therapeutics Market Challenges
11.4 Autoimmune Disease Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
